DWL Blog

DIA 2018

DWL Expo Schedule 2018 – Part 3 – DIA 2018 Global Annual Meeting

Part 3 – DIA 2018 Global Annual Meeting DIA 2018 – Boston, USA – 24-28 June – Booth #2238 This post is part of our DWL Expo Schedule 2018 series. For the full list, click here. Nearly two months after our last conference in London, we are attending the DIA Global Annual Meeting in Boston. The conference

Continue Reading

DWL IS HIRING: Translation Project Manager

DWL is hiring! We are looking for an experienced Project Manager to provide extra support for a busy translation service provider specialising in the life sciences. Job description: As a Project Manager at DWL you will: Handle key accounts as part of the project management team. Manage projects in the medical / pharmaceutical field, including for

Continue Reading
BioTrinity 2018

DWL Expo Schedule 2018 – Part 2 – BioTrinity 2018

Part 2 – BioTrinity 2018 London, UK – 23-25 April – Booth #32 This post is part of our DWL Expo Schedule 2018 series. For the full list, click here. Nearly a week after DIA Europe 2018 in Basel, we are attending BioTrinity 2018, held on our doorstep in Hammersmith. The event will bring together

Continue Reading
DIA Europe 2018

DWL Expo Schedule 2018

DWL provide language solutions to a wide variety of life science companies, particularly relating to pharmaceutical, medical, and regulatory affairs. Our busy Hammersmith office is a hub of constant activity: our project managers work with translators, customers, and local Health Authorities to ensure prompt delivery of translations to our global customers. That said, the work

Continue Reading

Celebrating women in the sciences for International Women’s Day

Throughout human history, science has progressed via a continuous process of trial and error, and some of the greatest breakthroughs have resulted from some amount of luck (something we have written about before), near-misses, and plenty of perseverance. Many people have gone to great and often dangerous lengths in pursuit of medical knowledge. Today, figures

Continue Reading

The Landscape for CROs post Brexit: An Update

UK still a key player The Clinical & Contract Research Association (CCRA) held a one-day session entitled The Landscape for CROs post Brexit—An Update on 31 January 2018 at the Royal Society of Medicine in London, one year on from a similar event in January 2017. The session was chaired by Dr Virginia Acha, Executive

Continue Reading

Spotlight on Cuba: How fostering business partnerships with Cuba could benefit the UK and global health industries

Recently, DWL met with a delegation from the Life Sciences sector in Cuba, as part of an initiative by the UK Department of International Trade. At the meeting were representatives from the Cuban Chamber of Commerce and other governmental bodies, as well as pharmaceutical and biotechnology agencies including BioCubaFarma, CECMED, CIGB and CIM-CIMAB. The aim

Continue Reading

EMA Human Medicines Highlights 2017 Out Now

The European Medicines Agency (EMA) has published its yearly overview of key recommendations for 2017, covering the authorisation of new medicines and related safety monitoring. The overview reveals the EMA recommended 92 medicines for approval. Of these, 35 contained new active substances never before authorized in the European Union. Most of these medicines are aimed

Continue Reading

What Makes A Good Translation for Regulatory Submission (And How To Avoid Being Let Down)

When you’ve worked hard to build your reputation, the last thing you need is your translation service provider letting you down. Without a full understanding of what makes a good translation, selecting your provider can quite literally be a gamble – especially with any extra costs associated with delays to submissions. To take the risk

Continue Reading


BREXIT: What lies ahead for the UK Life Sciences sector? DWL has received several questions about Brexit recently from translators but there is currently little hard information we can give them. What we do know from the government is that Brexit means Brexit…but Brexit means what for the UK’s life sciences sector? This was one

Continue Reading